Seller record · Telehealth service

Solaya MD

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the weight-loss, FAQ, company or policy pages. 2 more criteria also fail; see the table below.

At a glance

Solaya MDTelehealth service

5/8criteria passed
Price
Not printed before a consultation or sign-up
Sells
semaglutide, tirzepatide, sermorelin, and 1 more
FDA letters
None on file
Visit Solaya MDSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform offering semaglutide, tirzepatide and longevity treatments through independent medical providers, with prescribing decisions based on a health assessment.

Operating entity Solaya MD LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSSolaya MD's website; Solaya MD's terms of service page
S2Prescription gatingPASSSolaya MD's weight loss page
S3Pharmacy identificationPASSSolaya MD's FAQ
S4Compounding disclosurePASSSolaya MD's website
S5Analytical documentationFAILSolaya MD's weight loss page; Solaya MD's FAQ; Solaya MD's about page
S6Business addressFAILSolaya MD's contact page; Solaya MD's privacy policy; Solaya MD's FAQ
S7Price disclosureFAILSolaya MD's weight loss page; Solaya MD's terms of service page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSIndependent U.S.-licensed clinicians through MD Integrations evaluate the health assessment and retain discretion to prescribe, change or decline treatment.Source: Solaya MD's website; Solaya MD's terms of service page.
S2PASSThe published sequence begins with health questions, followed by clinician review, an eligibility decision and medication delivery.Source: Solaya MD's weight loss page.
S3PASSThe pharmacy FAQ identifies VialsRX at 6220 Westpark Dr, Houston, TX 77057 as the prescription fulfillment pharmacy.Source: Solaya MD's FAQ.
S4PASSThe home-page disclosure states that compounded medications are not FDA-approved and have not been evaluated for safety, effectiveness or quality.Source: Solaya MD's website.
S5FAILNo certificate of analysis or lot document is published on the weight-loss, FAQ, company or policy pages.Source: Solaya MD's weight loss page; Solaya MD's FAQ; Solaya MD's about page.
S6FAILThe contact and privacy pages provide telephone and email support but no postal address for Solaya MD. The pharmacy address identifies the dispensing pharmacy, not the platform business.Source: Solaya MD's contact page; Solaya MD's privacy policy; Solaya MD's FAQ.
S7FAILThe public weight-loss page describes semaglutide and tirzepatide options without stating a medication price. The terms list additional testosterone-program service fees rather than GLP-1 prices.Source: Solaya MD's weight loss page; Solaya MD's terms of service page.
S8PASSNo FDA warning letter names Solaya MD or Solaya MD LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, sermorelin, NAD+.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit Solaya MD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.